(Q37250734)

19 August 2017

Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions (English)

1 reference

19 August 2017

1 reference

Wee A

1

1 reference

19 August 2017

Teh M

series ordinal

2

1 reference

19 August 2017

Raju GC

series ordinal

3

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 May 1994

1 reference

Journal of Clinical Pathology

19 August 2017

1 reference

19 August 2017

47

1 reference

19 August 2017

453-456

1 reference

19 August 2017

5

1 reference

The p53 proto-oncogene can act as a suppressor of transformation

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502025

The p53 tumour suppressor gene

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502025

p53 in colorectal cancer: clinicopathological correlation and prognostic significance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502025

p53 mutations in human cancers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502025

Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502025

Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502025

P53 in tumour pathology: can we trust immunocytochemistry?

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502025

Altered expression of wild-type p53 tumor suppressor gene during murine epithelial cell transformation

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502025

p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502025

The precursor lesions of invasive gallbladder carcinoma. Hyperplasia, atypical hyperplasia and carcinoma in situ.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=502025

Overproduction of p53 antigen makes established cells highly tumorigenic

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8027399

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8027399

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/JCP.47.5.453

1 reference

19 August 2017

1 reference

19 August 2017

1 reference